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Abstract
 
Leukocyte trafficking to sites of inflammation follows a defined temporal pattern, and evidence
suggests that initial neutrophil transendothelial migration modifies endothelial cell phenotype.
We tested the hypothesis that preconditioning of human umbilical vein endothelial cells (HUVEC)
by neutrophils would also modify the subsequent transendothelial migration of T lymphocytes
across cytokine-stimulated HUVEC in an in vitro flow assay. Using fluorescence microscopy,
preconditioning of HUVEC by neutrophils was observed to significantly reduce the extent of
subsequent stromal cell–derived factor-1
 
 
 
 (SDF-1
 
 
 
 [CXCL12])-mediated T lymphocyte
transendothelial migration, without reducing accumulation. In contrast, recruitment of a second
wave of neutrophils was unaltered. Conditioned medium harvested after transendothelial migration
of neutrophils or supernatants from stimulated neutrophils mediated a similar blocking effect,
which was negated using a specific neutrophil elastase inhibitor. Furthermore, T lymphocyte
transendothelial migration was inhibited by treatment of HUVEC with purified neutrophil
elastase, which selectively cleaved the amino terminus of HUVEC-bound SDF-1
 
 
 
, which is
required for its chemotactic activity. The reduction in T lymphocyte transendothelial migration was
not observed using a different chemokine, ELC (CCL19), and was not reversed by replenish-
ment of SDF-1
 
 
 
, indicating endothelial retention of the inactivated chemokine. In summary,
transmigrating neutrophils secrete localized elastase that is protected from plasma inhibitors, and
thereby modulate trafficking of other leukocyte subsets by altering the endothelial-associated
chemotactic activities.
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Introduction
 
The inflammatory response is an important component of
innate immunity and a critical step is extravasation of leu-
kocytes through the blood vessel wall. In recent years, the
mechanisms and molecules involved in this process have
been widely studied (1, 2). In many respects, the trafficking
of T lymphocytes and neutrophils differs, despite the utili-
zation of common molecular mechanisms. This may, in
part, be due to the temporal expression of surface adhesion
molecules or certain chemokines, leading to preferential re-
cruitment of neutrophils or lymphocytes during the early
and late parts of an inflammatory response, respectively.
Additionally, in vitro studies have demonstrated that optimal
T lymphocyte transendothelial migration requires the pres-
ence of laminar flow as well as an apical chemokine stimu-
lus (3), which results in activation and polarization via a
Rap-1–dependent mechanism (4). Furthermore, T lym-
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, stromal cell derived factor-1
 
 
 
. 
Modulation of T Cell Transendothelial Migration by Neutrophils
 
714
phocyte subsets exhibit different adhesion and homing pat-
terns to nonlymphoid tissues, according to their memory/
naive phenotype (5, 6), their Th1/Th2 phenotype (7), and
their chemokine receptor status (8, 9).
Recent evidence suggests that the interaction of neutro-
phils with endothelial cells (ECs) results in phenotypic
changes in both ECs and neutrophils (for review see refer-
ence 10). Specifically, soluble products of neutrophil acti-
vation and transmigration can act in a pro- or antiinflam-
matory manner with respect to EC behavior (11–14). In
particular, neutrophil proteases regulate other important
inflammatory components such as chemokine activity
(15–17) and expression of surface or junctional adhesion
molecules (18, 19). Release of enzymes such as neutrophil
elastase is itself augmented through adhesion to ECs (20) or
to P-selectin (21).
Neutrophil trafficking has also been described to modu-
late the subsequent trafficking of other leukocyte subsets
through a number of different mechanisms. For example,
release of soluble IL-6 receptor from neutrophils has been
implicated in mediating a switch from a neutrophilic to a
mononuclear infiltrate (22), and neutrophil depletion re-
duces the capability of 
 
Leishmania
 
 
 
major
 
–infected mice to
mount an effective Th2 response (23). In contrast, mono-
nuclear cell infiltration into the peritoneum of LFA-1
 
   
 
mice (which have a relative defect in neutrophil trafficking)
is normal and is mediated by MCP-1 release from resident
macrophage and mesothelial cells (24). Most of these stud-
ies have examined the role of neutrophil trafficking on de-
layed leukocyte behavior. Few studies have examined the
effects of transendothelial migration of neutrophils on the
ability of ECs to support earlier T lymphocyte transendo-
thelial migration.
In this work, we demonstrate that human umbilical
vein ECs (HUVEC)–bound stromal cell–derived factor-1
 
 
 
(SDF-1
 
 
 
 [CXCL12])-associated, but not ELC (CCL19),
transendothelial migration of CD3
 
 
 
 T lymphocytes is at-
tenuated under flow conditions after transendothelial mi-
gration of an initial wave of neutrophils. This inhibition is
mediated by neutrophil elastase and appears to affect both
migration of T lymphocytes to the EC junction as well
subsequent transendothelial migration. These findings sug-
gest that locally secreted elastase from transmigrating neu-
trophils may be an important component in the regulation
of the evolving inflammatory response by down-regulating
early emigration of T lymphocytes and preventing the in-
flux of cells of a more chronic inflammatory phenotype.
 
Materials and Methods
 
Cells and Cell Lines.
 
HUVEC were isolated and cultured as
described previously (25). HUVEC (at subculture 2) were seeded
at 50% confluence on 25-mm glass coverslips (Assistent; Carolina
Biological Supply Company), coated overnight with 5 
 
 
 
g/ml fi-
bronectin (Sigma-Aldrich), and grown to confluence over 48 h.
Routinely, HUVEC were stimulated with 10 U/ml of recombi-
nant human IL-1
 
 
 
 (a gift from Biogen) for 4 h and, where indi-
cated, incubated with 20 ng/ml SDF-1
 
 
 
/CXCL12 or 200 ng/ml
ELC/MIP-3
 
 
 
/CCL19 (both obtained from PeproTech) in growth
medium (M199 
 
 
 
 20% FCS) at 37
 
 
 
C for 15 min before use (3).
Human neutrophils (
 
 
 
95% pure) were isolated from sodium-cit-
rated whole blood drawn from healthy volunteers using Histo-
paque 1077 (Sigma-Aldrich) centrifugation followed by 2% dex-
tran (Sigma-Aldrich) sedimentation and hypotonic red cell lysis as
described previously (26). Autologous human CD3
 
 
 
 or CD4
 
 
 
 T
lymphocytes (
 
 
 
90% pure, of which 50–60% were CD45RO
 
 
 
)
were isolated from the original sample by negative selection using
a RosetteSep T cell enrichment cocktail (StemCell Technologies
Inc.) according to manufacturer’s instructions. In experiments
with perfusion of both neutrophils and lymphocytes, T lympho-
cytes were prelabeled with 1 
 
 
 
M of Cell Tracker orange or green
(Molecular Probes) for 10 min at 37
 
 
 
C. Neutrophils were main-
tained at 8–10
 
 
 
C and T lymphocytes were maintained at 37
 
 
 
C
before use. In experiments in which autologous donor plasma
was also used, it was isolated by centrifugation of citrated whole
blood (300 
 
g
 
 for 20 min), followed by centrifugation to remove
platelets (1,000 
 
g
 
 for 20 min). Blood was drawn and handled ac-
cording to appropriate institutionally approved Institutional Re-
view Board protocols.
 
Generation of Conditioned Media from Neutrophil–EC Superna-
tants.
 
HUVEC were grown to confluence on 100-mm plastic
Petri dishes coated with 0.1% gelatin (Sigma-Aldrich) and stimu-
lated with 10 U/ml of recombinant human IL-1
 
 
 
 for 4 h or with
growth medium alone. Neutrophils (20 
 
 
 
 10
 
6
 
 in 3 ml flow
buffer, approximating a ratio of 2 neutrophils for each HUVEC)
were added to the apical surface and incubated under static con-
ditions at 37
 
 
 
C for 30 min. This resulted in robust transmigration
of neutrophils across activated, but not unactivated, HUVEC
monolayers. The supernatant from this incubation was harvested
and centrifuged at 200 
 
g
 
 for 10 min at room temperature. This
supernatant was further centrifuged at 1,000 
 
g
 
 for 10 min at 4
 
 
 
C
before use. Conditioned media generated in this way was added
to IL-1
 
 
 
/SDF-1
 
 
 
–stimulated HUVEC at 37
 
 
 
C for 10 min.
 
Generation of Activated Neutrophil Supernatants.
 
This protocol
was modified from one described previously (11). In brief, 10
 
8
 
cells/ml neutrophils were incubated with 10
 
 
 
6
 
 M FMLP in
HBSS for 60 s at 37
 
 
 
C and centrifuged at 200 
 
g
 
 at room tempera-
ture for 5 min. The supernatant was removed and further centri-
fuged at 1,000 
 
g
 
 for 10 min at 4
 
 
 
C before use. Supernatants gen-
erated in this way were either used immediately or stored at
 
 
 
20
 
 
 
C. Alternatively, supernatants were produced by stimulation
of neutrophils with 10
 
 
 
7
 
 M C5a or 10
 
 
 
8
 
 M IL-8 for 300 s and
harvested using the same conditions as FMLP. Supernatants were
added to IL-1
 
 
 
/SDF-1
 
 
 
–stimulated HUVEC at 37
 
 
 
C for 10
min. In certain experiments, these supernatants were pretreated
with 10 
 
 
 
M MeOSuc-AAPV-CMK, a specific, irreversible elas-
tase inhibitor (EI; Calbiochem) or 10 
 
 
 
M Z-GLF-CMK, a spe-
cific cathepsin G inhibitor (Enzyme Systems Products), both di-
luted in DMSO (itself at a final working concentration of 0.05%).
In other experiments, FMLP-stimulated neutrophil supernatants
were generated in the continued presence of 10 
 
 
 
M MeOSuc-
AAPV-CMK, 25% autologous plasma, or both before their addi-
tion to IL-1
 
 
 
/SDF-1
 
 
 
–stimulated HUVEC at 37
 
 
 
C for 10 min.
Alternatively, 33 nM of purified human neutrophil elastase (HNE;
Calbiochem) in 50 mM NaOAc/200 mM NaCl was used in
place of supernatants and, where indicated, this compound was
pretreated with the EI. In one series of experiments, flow buffer
(see next paragraph) was made up including either 0.05% DMSO
or 10 
 
 
 
M MeO-Suc-AAPV-CMK.
 
Leukocyte Adhesion and Transmigration Assay.
 
The in vitro
flow model has been described previously in detail (27). Conflu- 
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ent HUVEC monolayers on coverslips were inserted into the
flow chamber, and the entire chamber was mounted on an in-
verted differential interference contrast (DIC)– and fluorescence-
equipped microscope (Nikon) connected to an Orca ER camera
(Hamamatsu). Experiments were conducted using a 40 or 20
 
 
 
objective lens. Where indicated, to visualize EC junctional pro-
teins, HUVEC monolayers were labeled with either anti–VE-
cadherin, AlexaFluor-568 (Molecular Probes)–conjugated mAb,
TEA 1/31 (Immunotech), or with AlexaFluor-488–conjugated
anti–JAM-1 mAb, 1H2A9 (a gift from C. Parkos, Emory Univer-
sity, Atlanta, GA; reference 28). These mAb treatments have been
shown not to alter HUVEC barrier function or the dynamics of
neutrophil adhesion and transendothelial migration (unpublished
data). The initial wave of neutrophils was resuspended in flow
buffer (DPBS/0.1% HSA) at 0.5 
 
 
 
 10
 
6
 
/ml and drawn across the
HUVEC monolayer at an estimated shear stress of 1.0 dyne/cm
 
2
 
,
using a syringe pump (Harvard Apparatus) to minimize secondary
capture of flowing neutrophils (29). Neutrophils were drawn into
the chamber for 5 min to permit sufficient accumulation, fol-
lowed by flow buffer alone for 10 min to allow maximum trans-
migration to occur. Fluorescent CD3
 
 
 
 T lymphocytes (10
 
6
 
/ml)
were introduced at an estimated shear stress of 0.75 dynes/cm
 
2
 
 for
6 min to maximize accumulation, followed by buffer alone for 10
min while transmigration of T lymphocytes occurred. Where in-
dicated, SDF-1
 
 
 
 (20 ng/ml in flow buffer) was introduced at an
estimated shear stress of 0.5 dynes/cm
 
2
 
 for 10 min, followed by 5
min of flow buffer alone, preceded T lymphocyte perfusion. In
some experiments, flow buffer was supplemented with 10 or 25%
autologous plasma. For a more detailed diagrammatic scheme of
the experimental protocol, see Fig. 1 a.
 
Image Acquisition and Analysis.
 
Fluorescence and DIC images
were acquired using MetaMorph v4.6 software (Universal Imaging
Corp.) controlling a Uniblitz VMM-D1 shutter (Vincent Associ-
ates) and a Lambda 10–2 optical filter changer (Sutter Instrument
Co.). For transendothelial migration experiments, digital images
were taken every 15 s for 10 min in one representative field of view
from 3 min after T lymphocyte perfusion commenced. Where la-
beled T lymphocytes were used, both red fluorescence and DIC
images were acquired sequentially. Where unlabeled T lympho-
cytes were used, DIC-only images were obtained at the same fre-
quency. Acquired images were processed and analyzed using Con-
focal Assistant 4.02 shareware (Todd Clarke Brelje) and LaserSharp
2000 (Bio-Rad Laboratories). The number of sequentially accumu-
lated cells (either rolling, arrested, or transmigrated) was counted
for every minute of acquisition. The total number of accumulated
leukocytes was tabulated and the number of transmigrated neutro-
phils or T cells (both in total and over time) was calculated as a per-
centage of this value. For analysis of junctional migration of T lym-
phocytes, sequential automated DIC-red-green images were taken
from multiple fields of view using preprogrammed exposure times.
 
Generation of Biotinylated SDF-1
 
 
 
 Compounds and ESI-MS
Analysis of Elastase-mediated Proteolysis.
 
SDF-1
 
 
 
-C-ter-bt was
synthesized as described previously (30). This derivative retains the
proadhesive and promigratory activities of native SDF-1
 
 
 
 for T
lymphocytes when overlaid on activated HUVEC (unpublished
data). For SDF-1
 
 
 
-N-ter-bt, which does not bind its receptor
CXCR4, the biotin was incorporated on the amino-terminal
group before TFA cleavage of the protein resin. Chemokine puri-
fication and folding was identical as for SDF 1-67. Confirmation
of elastase degradation of SDF-1
 
 
 
-N-ter-bt by reverse phase
HPLC and subsequent electrospray ionization mass spectrometry
(ESI-MS) was performed as described previously (17).
 
Blotting of Cleaved SDF-1
 
 
 
 from EC Lysates.
 
HUVEC were
grown to confluence on 0.1% gelatin (Sigma-Aldrich)-coated
Figure 1. Pretreatment of IL-1 –
stimulated HUVEC with neutro-
phils reduces CD3  T lymphocyte
transmigration in response to SDF-1 .
(a) Confluent HUVEC were stimu-
lated with 10  L/ml IL-1  for 4 h,
treated with medium alone or 20
ng/ml SDF-1  before perfusion of
PBS/0.1%HAS (flow buffer) for 15
min. Alternatively, neutrophils (0.5  
106/ml) were drawn over these cells
for 5 min at 1.0 dynes/cm2, fol-
lowed by flow buffer for 10 min, to
allow robust transmigration. After
each of the pretreatments, T lym-
phocytes (1.0   106/ml, labeled
with Cell Tracker orange) were
drawn over HUVEC at 0.75 dynes/
cm2 for 6 min, followed by flow
buffer alone. Time–lapse DIC and
fluorescent images were acquired after
3 min of T lymphocyte perfusion for
10 min every 15 s. Experiments
were analyzed offline using image
analysis software (see Materials and
Methods). (b) After SDF-1  pre-
treatment of HUVEC monolayers,
T lymphocyte transendothelial mi-
gration was 30%. In the absence of
SDF-1 , transendothelial migration
of T lymphocytes cells was  5%. Neutrophil preconditioning of HUVEC under flow did not affect subsequent baseline T lymphocyte transendothelial
migration, but did significantly reduce that observed after SDF-1  pretreatment (*, P   0.05). With all pretreatments, (c) there was no delay in transen-
dothelial migration or (d) a reduction in the extent of subsequent T lymphocyte accumulation. (n   3, separate experiments). 
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six-well plates (Costar; Corning Inc.). Confluent ECs were stim-
ulated with IL-1  (for 4 h), incubated with either SDF-1 -N-
ter-bt or SDF-1 -C-ter-bt (200 ng/ml; reference 30) (as indi-
cated) for 30 min at 37 C, and washed three times with medium
199. HUVEC were treated with 33  M purified HNE or control
medium 199 at 37 C. ECs were lysed with boiling Tricine sam-
ple buffer (Bio-Rad Laboratories) under reducing conditions.
Proteins were separated by SDS-PAGE on a 16.5% acrylamide
Tris-Tricine gel (Bio-Rad Laboratories) at 4 C for 100 min at
100 V. Proteins were transferred to a nitrocellulose membrane
(Schleicher and Schuell) by wet transfer for 1 h at 4 C at 100 V.
The blot was probed with 1:2,000 streptavidin–horseradish per-
oxidase (HRP; Amersham Biosciences) and developed using en-
hanced chemiluminescence (Pierce Biotechnology).
Data and Statistics. Data are expressed as mean   SD for three
separate experiments performed using different HUVEC isolates,
with different leukocyte donors on separate days. Statistical signifi-
cance was assumed to be P   0.05 using one-way analysis of vari-
ance with Bonferroni post-test correction where appropriate.
Results
Perfusion of IL-1 –stimulated HUVEC with Neutrophils
Reduces Subsequent CD3  T Lymphocyte Transmigration in
Response to SDF-1 . CD3  T lymphocytes were labeled
with Cell Tracker orange and drawn across IL-1 –stimu-
lated HUVEC for 6 min, followed by buffer alone for 10
min. Lymphocyte adhesion and transendothelial migration
were assessed by time-lapse videomicroscopy and were
compared with that observed after pretreatment of endo-
thelium with either SDF-1 , a bolus of neutrophils per-
fused for 5 min and followed by buffer, or both (Fig. 1 a).
As reported previously (3), in the absence of SDF-1 ,
 5% of adherent CD3  T lymphocytes transmigrated
across IL-1 –stimulated HUVEC despite robust adhesion
to the HUVEC monolayer. After preincubation of
HUVEC with SDF-1 , transendothelial migration in-
creased significantly (Fig. 1 b), whereas adhesion remained
constant (Fig. 1 d). In contrast, perfusion and robust trans-
migration of neutrophils in the absence of SDF-1  did not
augment subsequent CD3  T lymphocyte transendothelial
migration. Surprisingly, in the presence of SDF-1 , prior
perfusion of neutrophils reduced CD3  T lymphocyte
transendothelial migration by 59% (n   4). Pretreatment of
HUVEC with neutrophils and/or SDF-1  did not either
cause a delay in CD3  T lymphocyte transendothelial mi-
gration (Fig. 1 c) or a reduction in the number of cells ac-
cumulated on HUVEC (Fig. 1 d). Purified CD4  T lym-
phocytes exhibited a similar reduction in transendothelial
migration (unpublished data). The presence of SDF-1  did
not alter the extent of neutrophil accumulation or rate of
transmigration (unpublished data).
Perfusion of Neutrophils Does Not Alter Subsequent Neutro-
phil Transmigration. Transendothelial migration of neutro-
phils across IL-1 –stimulated HUVEC is observed under
flow conditions in the absence of SDF-1 . Therefore, we
examined whether the neutrophil inhibition of transendo-
thelial migration was still observed if the second cohort of
leukocytes was a population of neutrophils, rather than T
lymphocytes. In this case, the second cohort of neutrophils
was fluorescently labeled (to distinguish them from the first
cohort) and perfused 10 min after the first. Transendothe-
lial migration of the first cohort was compared with that of
the second, as well as a cohort perfused after flow buffer
alone (either under static or flow conditions for 15 min).
No alteration in the extent or rate of transendothelial mi-
gration (Fig. 2, a and b) or in accumulation (Fig. 2 c) of the
second wave of neutrophils was observed under any of
these conditions. This suggests that the reduction in trans-
migration is specific for T lymphocytes and does not repre-
sent a global down-regulation of the capacity of HUVEC
to support leukocyte transendothelial migration.
The Neutrophil-mediated Reduction in SDF-1 –associated
CD3  T Lymphocyte Transmigration Is Chemokine Specific and
Is Not Reconstituted after Replenishment of SDF-1 . A sec-
ond chemokine, ELC (CCL19, MIP-3 ) is also known to
augment T lymphocyte transendothelial migration in this
system (3). Therefore, to test whether T lymphocyte trans-
endothelial migration in response to a different chemokine
was reduced by neutrophil perfusion, 200 ng/ml ELC was
used in place of SDF-1 . As reported previously, T lym-
phocyte transendothelial migration was observed. Interest-
ingly, after priming with neutrophils, no reduction of T
lymphocyte transendothelial migration was observed (Fig. 3
a) demonstrating the specificity of this effect for SDF-1 –,
but not ELC-associated transmigration.
One potential explanation for the observation that trans-
migration of T lymphocytes across HUVEC in response to
SDF-1  is attenuated is that apically presented chemokine
is dislodged or bound by the initial wave of neutrophils, al-
though certain lines of evidence suggest that the SDF-1 
Figure 2. Neutrophil preconditioning does not affect the subsequent
interaction of neutrophils across IL-1 –stimulated HUVEC. Confluent
IL-1 –stimulated HUVEC monolayers were exposed to control, buffer
with no flow, buffer at 1 dyne/cm2 (each for 15 min), or neutrophils
drawn across at 1 dyne/cm2 for 5 min followed by buffer for 10 min, as
before. Neutrophils were drawn across the HUVEC monolayer at 1
dyne/cm2 for 5 min, followed by buffer alone for 10 min. The (a) extent
and (b) rate of transendothelial migration and (c) accumulation of the second
cohort of neutrophils was not affected by HUVEC preconditioning with
either flow buffer or a first wave of neutrophils (n   3, separate experiments).Rao et al. 717
receptor, CXCR4, is minimally expressed on freshly iso-
lated peripheral blood neutrophils (31–33). To examine
this possibility, the chemokine was replenished under flow
after initial neutrophil perfusion. Delivery of SDF-1  in
this manner was at least as effective as preincubation under
static conditions because the extent of T lymphocyte trans-
endothelial migration was similar for either condition (Fig.
3 b). After replenishment of SDF-1  and after trans-
endothelial migration of neutrophils, labeled T lympho-
cytes were perfused and observed again. There was no
restoration of T lymphocyte transendothelial migration
(Fig. 3 b), although the number of accumulated cells was
the same. Together, these data demonstrate that neutrophil
transmigration specifically reduces T lymphocyte migration
in response to SDF-1 , but not ELC, and furthermore that
it is unlikely that SDF-1  is dislodged by neutrophils be-
cause its replenishment does not reconstitute T lymphocyte
transendothelial migration.
Conditioned Medium from Neutrophil–HUVEC Transmigra-
tion Interactions Can Mediate a Reduction in T Lymphocyte
Transendothelial Migration. Next, we considered whether
the process of transmigration of neutrophils across IL-1 –
stimulated HUVEC could release a soluble mediator capa-
ble of reducing subsequent T lymphocyte transendothelial
migration. To assess this, conditioned medium was gener-
ated by incubating neutrophils (20   106 in 3 ml of flow
buffer) with IL-1 –stimulated HUVEC under static condi-
tions for 30 min as detailed in Materials and Methods. Sig-
nificant transendothelial migration of neutrophils was ob-
served across stimulated, but not unstimulated, HUVEC.
The conditioned medium from each of these interactions
was used to pretreat IL-1 /SDF-1 –stimulated HUVEC
for 5 min at 37 C before perfusion of T lymphocytes. Sig-
nificant reduction of T lymphocyte transendothelial migra-
tion was observed after pretreatment of HUVEC with
conditioned medium from stimulated neutrophil–HUVEC
interactions, but not with conditioned medium from un-
stimulated neutrophil–HUVEC interactions (control me-
dium) (Fig. 4 a). There was no delay in transendothelial
migration nor was there a reduction the number of accu-
mulated cells (not depicted).
Supernatants from Neutrophils Stimulated with FMLP, C5a,
or IL-8 Can Also Reduce T Lymphocyte Transendothelial
Migration. Next, we examined whether a soluble factor
released directly from interacting neutrophils might con-
tribute to a reduction in T lymphocyte transendothelial
migration. Preconditioning of IL-1 –stimulated/SDF-1 –
pretreated HUVEC with FMLP-stimulated neutrophil
supernatants for 5 min reduced T lymphocyte transendo-
thelial migration, whereas preconditioning with superna-
tants from unstimulated neutrophils or with FMLP alone
Figure 3. The neutrophil-mediated reduction in SDF-1 –associated
CD3  T lymphocyte transmigration is chemokine specific and is not re-
constituted after replenishment of SDF-1 . IL-1 –stimulated HUVEC
were incubated with either SDF-1  or ELC. Labeled T lymphocytes
were perfused and transendothelial migration was assessed with DIC/
fluorescence time-lapse microscopy with or without a prior bolus of neu-
trophils. (a) Preconditioning of EC with neutrophils reduced subsequent
SDF-1 –associated T lymphocyte transendothelial migration, as shown
previously; however, a similar reduction in ELC-associated T lymphocyte
transendothelial migration was not observed. (b) 20 ng/ml SDF-1  was
perfused into the flow chamber and was as effective at mediating T cell
transendothelial migration as preincubation with SDF-1 . Replenish-
ment with SDF-1  after transendothelial migration of neutrophils did not
result in a rise in the percentage of T lymphocyte transendothelial migration
back to baseline (*, P   0.05). There was no delay in transendothelial migra-
tion, and the number of accumulated cells (not depicted) was not signifi-
cantly different between all conditions (n   3, separate experiments).
Figure 4. Supernatants generated after either transendothelial migra-
tion of neutrophils or activation of neutrophils modulate T lymphocyte
transendothelial migration across IL-1 –stimulated HUVEC. Neutrophils
were coincubated with unstimulated (control) or IL-1 –stimulated (con-
ditioned) HUVEC, and the supernatants from these reactions were harvested
after 30 min and used to pretreat IL-1 /SDF-1 –stimulated HUVEC (see
Materials and Methods). (a) T lymphocyte transendothelial migration was
significantly reduced after treatment of HUVEC with conditioned, but
not control medium (*, P   0.01, n   3). (b) In separate experiments,
neutrophils were activated with FMLP, and the supernatants were har-
vested (see Materials and Methods) and used to pretreat IL-1 /SDF-1 –
stimulated HUVEC. Compared with supernatants from unactivated neu-
trophils or with FMLP alone, the extent of T lymphocyte transendothelial
migration was significantly reduced (*, P   0.05, n   3) after pretreat-
ment of HUVEC with FMLP-activated neutrophil supernatants. (c) A
similar reduction in T lymphocyte transendothelial migration across IL-1 /
SDF-1 –stimulated HUVEC after pretreatment of HUVEC with super-
natants from neutrophils stimulated with either 10 6 M FMLP, 10 7 M
C5a, or 10 8 M IL-8 (*, P   0.05, n   3).Modulation of T Cell Transendothelial Migration by Neutrophils 718
had no effect on baseline T lymphocyte transendothelial
migration (Fig. 4 b). There was no delay in transendothelial
migration, and accumulation of T lymphocytes was unaf-
fected in all cases (not depicted). Supernatants from neutro-
phils stimulated with either C5a or IL-8 could also mediate
a significant reduction in T lymphocyte transendothelial
migration (Fig. 4 c). These data demonstrate that a secreted
neutrophil product can mediate a reduction in SDF-1 –
associated T lymphocyte transendothelial migration.
Neutrophil Elastase Mediates a Reduction in T Lymphocyte
Transendothelial Migration. Of interest, both neutrophil-
derived MMP-2 (16) and elastase (17) have been reported to
reduce the activity of SDF-1  by cleavage of the amino-ter-
minus, although both previous papers used prolonged incu-
bation of purified protein. Mononuclear cell–derived ca-
thepsin G has also been reported to cleave SDF-1  (34).
Thus, we postulated that neutrophil-derived elastase might
account for the inactivation of some or all of the apically
presented chemokines on HUVEC that are mandatory for T
lymphocyte transendothelial migration. Elastase activity in
FMLP-activated neutrophil supernatants was quantified and
was found to be equivalent to 33 nM purified HNE (unpub-
lished data). The FMLP-activated neutrophil supernatants
were pretreated for 20 min with either 10  M MeO-Suc-
AAPV-CMK (a specific EI), 10  M Z-GLF-CMK (a specific
cathepsin G inhibitor, CGI), or 0.05% DMSO (as vehicle
control) before addition for 10 min to IL-1 /SDF-1 –stim-
ulated HUVEC at 37 C. Treatment with the EI, but not ca-
thepsin G inhibitor or DMSO, abrogated the blocking effect
of FMLP-neutrophil supernatant (Fig. 5 a). Similarly, addi-
tion of 33 nM HNE to IL-1 /SDF-1 –stimulated HUVEC
at 37 C for 10 min reproduced the inhibitory effect of
FMLP-neutrophil supernatants in reducing T lymphocyte
transendothelial migration by  60%. This effect of HNE
was prevented by treatment with MeO-Suc-AAPV-CMK
(EI). Next, we incubated SDF-1  with the same inhibitor
or compound before addition to IL-1 –stimulated HUVEC
to demonstrate a direct, elastase-dependent effect of FMLP-
neutrophil supernatants on chemokine function. Sham treat-
ment (0.05% DMSO) of SDF-1  resulted in a reduction in
transendothelial migration of T lymphocytes by 50% to that
observed in the absence of DMSO (Fig. 1 b), perhaps re-
flecting an effect due to manipulation or dilution of SDF-
1 . However, incubation with either FMLP-neutrophil su-
pernatant or 33 nM HNE still resulted in further reduction
in T lymphocyte transendothelial migration to  5% (Fig. 5
b). As expected, addition of EI to FMLP-neutrophil super-
natant before incubation with SDF-1  reversed its ability to
inactivate the chemokine.
to confirm the rapid cleavage of the amino terminus to a smaller 7507 D
species, as described previously for SDF-1 -C-ter-bt (not depicted). (d) To
demonstrate direct cleavage of SDF-1  by HNE on HUVEC, either
SDF-1 -N-ter-bt or SDF-1 -C-ter-bt was added to IL-1 –stimulated
HUVEC, and treated with either control, or purified HNE (33  M) for
5 min. Lysates were separated on a 16.5% Tris-tricine gel and probed
with HRP-streptavidin and analyzed by chemiluminescence. Loss of the
amino terminal was confirmed by loss of biotin signal from SDF-1 -N-ter-
bt, but not from SDF-1 -C-ter-bt.
Figure 5. Neutrophil elastase reduces T lymphocyte transendothelial
migration across IL-1 /SDF-1 –stimulated HUVEC and can directly in-
hibit the effect of SDF-1 . T lymphocyte transendothelial migration was
observed across stimulated HUVEC after treatment of HUVEC with ei-
ther FMLP-activated neutrophil supernatants preincubated with either
DMSO, as vehicle, 10  M MeOSucc-AAPV-CMK, a leukocyte elastase
inhibitor (EI), 10  M Z-GLF-CMK, a cathepsin G inhibitor (CGI), purified
human neutrophil elastase (HNE), or HNE plus EI. (a) Elastase inhibition
(EI) resulted in a reversal in the ability of neutrophil supernatants to reduce T
lymphocyte transendothelial migration compared with vehicle alone
(DMSO) or cathepsin G inhibitor (CGI). Similarly, treatment of HUVEC
with purified HNE reproduced a reduction in T lymphocyte transendothelial
migration that was reversed with pretreatment with EI (HNE   EI) (*, P  
0.05, n   3). (b) In a similar series of experiments, SDF-1  was treated
with either DMSO alone (sham) or with FMLP-neutrophil supernatants,
themselves preincubated with either DMSO or EI or with HNE before
addition to activated HUVEC monolayers. There was an overall reduc-
tion in baseline T lymphocyte transendothelial migration (by  50%), but
elastase inhibition still resulted in a reversal in the ability of neutrophil super-
natants to inhibit T lymphocyte transendothelial migration. Likewise, purified
HNE treatment of SDF-1  resulted in a decrease in T lymphocyte
transendothelial migration. (c) SDF-1  biotinylated at the NH2 terminal
(SDF-1 -N-ter-bt, 8171 D) was treated with HNE and analyzed by ESI-MSRao et al. 719
To further examine this phenomenon, we used SDF-1 ,
biotinylated either at the carboxy (SDF-1 -C-ter-bt) or
amino (SDF-1 -N-ter-bt) terminus. SDF-1 -C-ter-bt is
rapidly cleaved by purified HNE when in solution as de-
scribed previously (17), and the same property was con-
firmed by mass spectrometry for SDF-1 -N-ter-bt. After
incubation with HNE,  90% of the synthetic chemokine
was cleaved to a 7,507 D species and  10% was the origi-
nal uncleaved 8,171 D parent species (Fig. 5 c). To confirm
that purified HNE could directly cleave the SDF-1 
bound to HUVEC monolayers, we incubated IL-1 –stim-
ulated HUVEC with each synthetic SDF-1  compound.
After treatment with purified HNE, HUVEC lysates were
resolved on a 16.5% Tris-Tricine gel and SDF-1 –biotin
species were detected with HRP-streptavidin. Although
both compounds are susceptible to elastase cleavage of the
amino terminal, the biotin conjugate was lost only from
SDF-1 -N-ter-bt, whereas little loss of biotin signal from
SDF-1 -C-ter-bt was observed. This series of experiments
confirmed the ability of HNE to cleave the functional NH2
terminus of HUVEC-bound SDF-1 , resulting in a signifi-
cant reduction in the ability of truncated SDF-1  to trigger
T lymphocyte transendothelial migration.
Figure 6. Whole neutrophils, but not treatment with stimulated
neutrophil supernatants, reduces T lymphocyte transendothelial migra-
tion in the presence of autologous plasma. (a) T lymphocytes were
drawn across stimulated HUVEC in normal flow buffer or flow buffer
supplemented with 10 or 25% autologous plasma (white bars). Inclu-
sion of either 10 or 25% autologous plasma did not affect the ability of
whole neutrophils to reduce subsequent T lymphocyte transendothelial
migration (black bars; *, P   0.05, n   3). In contrast, inclusion of 10
or 25% autologous plasma did reverse the ability of FMLP-neutrophil
supernatants to mediate a similar reduction (diagonally striped bars).
(b) When FMLP-neutrophil supernatants were generated in the presence
of DMSO, a significant reduction in T lymphocyte transendothelial
migration compared with control (no supernatant added) was observed
(* P   0.05, n   2). However, if these supernatants were generated in
the presence of either EI, 25% plasma, or EI   25% plasma, this reduc-
tion was not observed. (c) In a separate series of experiments, the effect
of neutrophil preconditioning on T lymphocyte transendothelial mi-
gration across IL-1 /SDF-1 –stimulated HUVEC was observed in the
continued presence of 10  M MeO-Succ-AAPV-CMK (EI) or vehicle
control (DMSO). In this case, elastase inhibition partially reversed the
capacity of neutrophil preconditioning to mediate a reduction in T
lymphocyte transendothelial migration, whereas DMSO had no effect
(*, P   0.05, n   3).
Figure 7. Pretreatment with neutrophils reduces the capacity of T
lymphocytes to migrate to EC junctions associated with a reduction in
polarization in response to SDF-1 . T lymphocytes, labeled with Cell
Tracker green, were perfused over stimulated HUVEC that had been
stained with an anti–VE cadherin, AlexaFluor 568–conjugated antibody
to clearly visualize HUVEC junctions. Data are expressed as percentages
of all T lymphocytes interacting during the time course of observation.
The behavior of T lymphocytes was observed under high power (40 ) to
determine whether cells remained attached to the monolayer (Non-
junctional), migrated to and remained at HUVEC junctions (junctional),
or underwent transendothelial migration. In the presence of SDF-1 , the
majority of cells ( 90%) either underwent transendothelial migration or
remained at HUVEC junctions. In contrast, in the absence of SDF-1 , or
in the presence of SDF-1  and neutrophil preperfusion,  50% of T lym-
phocytes either underwent transendothelial migration (reference 3) or re-
mained at HUVEC junctions. We observed the same behavior when
these experiments were performed in 25% autologous plasma. No alter-
ation in localization or intensity of VE-cadherin staining or in HUVEC
confluence was observed with any of these treatments (not depicted).Modulation of T Cell Transendothelial Migration by Neutrophils 720
Autologous Plasma Inhibits the Proteolytic Activity of Neutro-
phil Supernatants, But Not That of Intact Neutrophils. En-
dogenous plasma-born protease inhibitors could potentially
neutralize the capability of HNE to mediate SDF-1  pro-
teolysis. Therefore, the ability of either adhesive/transmi-
grating neutrophils or neutrophil-derived supernatants to
mediate reduction in T lymphocyte transendothelial migra-
tion was examined in the presence of autologous plasma.
Perfusion of neutrophils in the presence of either 10 or
25% autologous plasma could still mediate a reduction in
subsequent T lymphocyte transendothelial migration; in
contrast, the ability of FMLP-stimulated neutrophil super-
natants to mediate a parallel reduction was now lost (Fig. 6
a). Similarly, if these supernatants were generated in buffer
supplemented with either 10  M Meo-Suc-AAPV-CMK,
25% autologous plasma, or both, their ability to mediate a
reduction in T lymphocyte transendothelial migration was
also lost (Fig. 6 b).
In addition, neutrophils were perfused across IL-1 /
SDF-1 –stimulated HUVEC before T lymphocytes again
in the continued presence of the EI MeO-Suc-AAPV-
CMK (or 0.05% DMSO as vehicle control). In this case, T
lymphocyte transendothelial migration was reduced in the
presence of 0.05% DMSO, but only partially when 10  M
MeO-Suc-AAPV-CMK was included in the assay (Fig. 6
c), suggesting that a small molecule inhibitor of elastase
could mediate a partial reversal in the neutrophil-mediated
effects on T lymphocyte transendothelial migration.
Neutrophil Transmigration Reduces Migration of T Lympho-
cytes to HUVEC Junctions before Transendothelial Migration.
T cell transmigration is predominantly paracellular and,
therefore, arrested lymphocytes must first undergo chemo-
kine-driven migration on the endothelial surface toward in-
tercellular junctions (35). In this system, addition of SDF-1 
potentiates junctional migration and transmigration, but not
initial accumulation. To examine whether neutrophil pre-
conditioning of IL-1 /SDF-1 –treated HUVEC monolay-
ers affected surface migration of T lymphocytes, HUVEC
were labeled with a nonblocking fluorescent antibody to the
adherens junction protein VE-cadherin. The ability of ad-
herent T lymphocytes to migrate to junctions and undergo
subsequent transendothelial migration was examined using a
40  objective. Consistent with previous reports (35), in the
absence of SDF-1 , adherent T lymphocytes did not consis-
tently migrate to HUVEC junctions (Fig. 7). In contrast, in
the presence of SDF-1 , the majority of cells migrated to
HUVEC junctions with a fraction subsequently undergoing
transendothelial migration. After neutrophil transmigration
across IL-1 /SDF-1  HUVEC monolayers, the percentage
of T lymphocytes that failed to position at HUVEC junc-
tions or subsequently transmigrate was significantly higher
despite comparable accumulation of T lymphocytes (Fig. 7).
We observed the same behavior when 25% autologous
plasma was included in the flow buffer. This suggests that
transmigrating neutrophils impair the ability of HUVEC-
associated SDF-1  to support the migration of T lympho-
cytes toward cell junctions, a key step in subsequent transen-
dothelial migration (35).
Discussion
Our data have demonstrated a significant reduction in
SDF-1 –associated T lymphocyte transendothelial migra-
tion across cytokine-stimulated HUVEC under in vitro
flow conditions immediately after transendothelial migra-
tion of neutrophils. This effect can be reproduced by condi-
tioned medium from neutrophil–HUVEC interactions or
supernatants from neutrophils stimulated with FMLP, C5a,
or IL-8. This effect is mediated by the release of neutrophil
elastase, which causes inactivation of apically presented
SDF-1  by cleavage of its NH2 terminal, a process pro-
tected from endogenous plasma-born EIs. Of considerable
interest is that this novel mechanism appears to be important
for attenuation of endothelial-bound SDF-1  function but
does not occur when the promigratory chemokine is ELC.
We did not witness a reduction in the number of accu-
mulated T lymphocytes after neutrophil transmigration.
This is noteworthy as neutrophil-derived elastase and ca-
thepsin G have also been reported to rapidly ( 15 min)
cleave PSGL-1 (18), an important mediator of initial neu-
trophils and T lymphocyte attachment, as well as VCAM-1
(albeit in bone marrow stroma; reference 36). EC-derived
nitric oxide also possesses antiadhesive properties (37), and
other neutrophil-derived products have been reported
to possess antiinflammatory activity, notably adenosine/
5 AMP (11, 38).
Junctional Adhesion Molecule Distribution Is Not Altered by
Transendothelial Migration of Neutrophils. Another poten-
tial explanation for our findings could be that transendo-
Figure 8. Schematic representation of HNE cleavage of apically pre-
sented SDF-1 . (first row) Neutrophil transendothelial migration with
localized elastase secretion (gray triangles) at the leading edge of the cell.
This elastase release is protected from endogenous protease inhibitors (see
Fig. 6 a and Autologous Plasma Inhibits the Proteolytic Activity of Neu-
trophil Supernatants, But Not That of Intact Neutrophils). (second row)
Truncation of NH2 terminus of junctional SDF-1 . Apically presented
SDF-1  (white dots), located at or near EC junctions, is cleaved at the
amino terminus, producing inactive SDF-1  (black dots), primarily at or
near HUVEC junctions. (third row) Normal T cell accumulation but fail-
ure of SDF-1a to trigger T cell locomotion and subsequent transendothe-
lial migration. Although primary accumulation is unimpaired, truncated
SDF-1  is unable to promote T lymphocyte migration and subsequent
transendothelial migration.Rao et al. 721
thelial migration of neutrophils affects the function or dis-
tribution of junctional adhesion molecules. We and others
have previously demonstrated reversible changes during
leukocyte transendothelial migration in the distribution of
junctional proteins such as VE-cadherin, PECAM-1, and
JAM-A (25, 26, 39–41). Our previous observations suggest
that such changes were transient and fully reversible. In ad-
dition, our observation that a defect occurs not only in
transendothelial migration but also in the preceding step of
migration to the HUVEC junction would reiterate the
view that the distribution and function of junctional adhe-
sion molecules is unaffected at this level. Furthermore, it
would be expected that any major redistribution of these
proteins would similarly affect transendothelial migration of
neutrophils as well as that of T lymphocytes in response to
other chemokines (e.g., ELC).
The Selective Effect of Neutrophil-derived Elastase on SDF-
1 –induced Transendothelial Migration of T Lymphocytes.
We have demonstrated a role for HNE, but not cathepsin
G, by both inhibiting the effects of FMLP-neutrophil su-
pernatant on T lymphocyte transendothelial migration with
a specific inhibitor and by confirming these observations
with purified neutrophil elastase. Although neutrophil-
derived serine proteases are secreted during transendothelial
migration (42) and may induce disorganization of HUVEC
junctions (19), it remains unclear whether HNE has a di-
rect role in the migration of neutrophils through HUVEC
junctions (43, 44). From our data, it would appear that any
effect of HNE on junctional proteins may be transient as
no reduction in transendothelial migration of a subsequent
population of neutrophils was observed. However, neutro-
phil-derived enzymes selectively truncate multiple chemo-
kines resulting in alteration in their function (16, 17, 34,
45, 46). These papers have used prolonged incubation of
these enzymes with the respective chemokines in solution,
and pertain to chemokine processing in the extravascular
space. To our knowledge, our work is the first demonstra-
tion of in situ modulation of chemokine activity at the
blood vessel wall by transmigrating blood-born cells.
The physiological impact of our results is further sub-
stantiated by the observation that, even in the presence of
autologous plasma, transmigration of HUVEC by neutro-
phils can still impair SDF-1 –associated T lymphocyte
transendothelial migration and migration to the junction.
Neutrophil elastase has been reported to circumvent in-
activation by its endogenous inhibitors using a variety of
mechanisms. These include compartmentalization away
from serum protease inhibitors (47), by remaining bound
to the neutrophil surface (48) or its substrate (49), or by se-
cretion of mediators that inactivate protease inhibitors (50,
51). Elastase has been reported to be released at the lead-
ing edge of the transmigrating (rather than adherent) neu-
trophils (42). The current paradigm for T lymphocyte
transendothelial migration proposes that cells sequentially
attach, arrest, polarize, and migrate to EC junctions before
transendothelial migration (3). Our observation in this
work is that without SDF-1 , or after neutrophil priming
in the presence of SDF-1 , T lymphocytes exhibit a defect
in migration and positioning at the HUVEC junction as
well as in subsequent transendothelial migration but not
initial, nonjunctional accumulation. Therefore, it would
seem reasonable to speculate that selective elastase-medi-
ated cleavage of SDF-1  occurs preferentially at the
HUVEC junction and is protected from plasma inhibitors
(as outlined in Fig. 8). At the apical surface, on the other
hand, HNE may not be released or its activity could be in-
hibited by plasma inhibitors.
Notably, replenishment of SDF-1  (or of a second che-
mokine, TARC; unpublished data) immediately after per-
fusion of neutrophils did not reconstitute T lymphocyte
transendothelial migration and we could also still detect
SDF-1 -C-ter-bt after HNE treatment. Therefore, this
would suggest that NH2 terminally cleaved inactive SDF-
1  occupies structures on inflamed HUVEC that might
otherwise serve to present native SDF-1 , or other chemo-
kines, such as TARC. Thus, generation of truncated che-
mokine products by neutrophils could result in distinct
outcomes depending on the type and distribution of the
proteolysed chemokine.
Both SDF-1  and its receptor CXCR4 are widely dis-
tributed and have well-described roles in the physiology of
hematopoetic (52), angiogenic (53), and neurological (54)
systems as well as in activation and/or recruitment of leuko-
cytes and stem cells (55). They are implicated in the patho-
genesis of a number of disease processes including rheuma-
toid arthritis (56), metastatis (57), and HIV encephalitis and
dementia (58). Hence, the observation that transendothelial
migration of neutrophils specifically down-regulates SDF-
1  function, while preserving the potency of other chemo-
kines (e.g., ELC), might represent an important control
mechanism in evolving inflammation. This mechanism is of
potential significance with respect to regulating early lym-
phocyte recruitment, which may have potentially deleteri-
ous effects, as well as to other SDF-1 –dependent processes
characteristic of chronic disease, such as stem cell recruit-
ment and angiogenesis. It is of interest that a similar mecha-
nism has been described in vivo after GM-CSF stimulation,
whereby neutrophil elastase, but not cathepsin G, cleaves
SDF-1  expressed on bone marrow stroma, inhibiting re-
tention and facilitating the subsequent mobilization of stem
cells from bone marrow into the peripheral circulation (59,
60), a process which may augment the CXCL1-dependent
release of cells from the bone marrow (33). In addition,
CXCR4 appears to be up-regulated on senescent neutro-
phils and, thus, mediates their SDF-1 –dependent return to
the bone marrow (33). It would be of interest to examine
whether senescent neutrophils can cleave bone marrow EC
SDF-1  and thereby influence haematopoetic progenitor
cell recirculation through bone marrow compartments (55).
In summary, we have described a novel regulatory level
in T lymphocyte recruitment to inflammatory sites, in
which transmigration of inflamed HUVEC by neutrophils
results in a reduction in chemokine triggered T lympho-
cyte diapedesis. The observation that the recruitment of
one type of immune cell modulates the migratory behavior
of another type indicates that trafficking of leukocytes isModulation of T Cell Transendothelial Migration by Neutrophils 722
not only dictated by endothelial-specific signals, but also by
the leukocyte response to these signals.
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